VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

KALA BIO, Inc. (KALA) Total Return Calculator with Dividends Reinvested

KALA BIO, Inc.

Popular:

The total return for KALA BIO, Inc. (KALA) stock is -96.66% over the past 12 months. So far it's down 81.47% this year. The 5-year total return is -99.96%, meaning $10,000 invested in KALA stock 5 years ago would be worth $4 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in KALA 1 year ago, it would be worth $334 today — you'd have lost $9,666.

With Dividends Reinvested$334-96.66%

Price Only (No DRIP)$334-96.66%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in KALA

1Y$334-$9,666 (-96.7%)-96.7% CAGR

3Y$73-$9,927 (-99.3%)-80.6% CAGR

5Y$4-$9,996 (-100.0%)-78.7% CAGR

10Y$1-$9,999 (-100.0%)-59.3% CAGR

15Y$1-$9,999 (-100.0%)-45.1% CAGR

20Y$1-$9,999 (-100.0%)-36.2% CAGR

30Y$1-$9,999 (-100.0%)-25.9% CAGR

KALA BIO, Inc. did not pay dividends during this period. Total return = price return.

Loading KALA total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-81.47%	—	-81.47%	—	$1,853
1Y	-96.66%	-96.66%	-96.66%	—	$334
3Y	-99.27%	-80.61%	-99.27%	—	$73
5Y	-99.96%	-78.71%	-99.96%	—	$4
10Y	-99.99%	-59.32%	-99.99%	—	$1
15Y	-99.99%	-45.10%	-99.99%	—	$1
20Y	-99.99%	-36.20%	-99.99%	—	$1
30Y	-99.99%	-25.91%	-99.99%	—	$1

Risk & Highlights

Best Year+76.56%2020

Worst Year-92.79%2025

Max Drawdown-99.46%2025-09-19 → 2026-04-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-38.81%	-38.81%	—	+0.41%	-39.2pp
2025	-92.79%	-92.79%	—	+16.64%	-109.4pp
2024	-0.14%	-0.14%	—	+24.00%	-24.1pp
2023	-78.09%	-78.09%	—	+24.81%	-102.9pp
2022	-44.31%	-44.31%	—	-19.95%	-24.4pp

KALA underperformed the S&P 500 by 127.99pp over the past year (-96.66% vs +31.32%).

Loading summary...

KALA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
KALAKALA BIO, Inc.	$855,530	-33.4%	-81.5%	-96.7%	—	-99.3%	-100.0%	-100.0%
OCULOcular Therapeutix, Inc.	$2.1B	+20.3%	-17.9%	+35.2%	—	+51.7%	-38.8%	-4.4%
LNTHLantheus Holdings, Inc.	$5.6B	+13.5%	+28.1%	-17.8%	—	-9.1%	+290.0%	+4002.4%
HROWHarrow Health, Inc.	$1.5B	+14.6%	-19.3%	+67.0%	—	+47.5%	+389.3%	+988.4%
SGHTSight Sciences, Inc.	$232M	+21.1%	-42.5%	+53.0%	—	-59.1%	-87.2%	-87.2%
NVCRNovoCure Limited	$1.9B	+56.4%	+25.7%	+1.0%	—	-76.2%	-91.5%	+31.0%
RCKTRocket Pharmaceuticals, Inc.	$418M	+11.6%	+11.6%	-38.8%	—	-81.9%	-91.1%	-90.7%
REPLReplimune Group, Inc.	$272M	-60.0%	-61.6%	-54.4%	—	-81.1%	-90.4%	-77.4%
BEAMBeam Therapeutics Inc.	$3.3B	+33.4%	+19.1%	+102.2%	—	-3.0%	-53.9%	+72.4%
EDITEditas Medicine, Inc.	$311M	+16.7%	+54.9%	+138.7%	—	-67.0%	-90.8%	-89.5%
CRSPCRISPR Therapeutics AG	$5.3B	+12.1%	+2.4%	+66.1%	—	-1.6%	-48.9%	+290.9%

Compare:KALA vs OCUL KALA vs LNTH KALA vs HROW KALA vs OCUL vs LNTH

About KALA Dividend Returns

KALA BIO, Inc. (KALA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of KALA over the past year?

KALA BIO, Inc. (KALA) delivered a return of -96.66% over the past year. Since KALA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in KALA be worth today?

A $10,000 investment in KALA BIO, Inc. one year ago would be worth $334 today, representing a loss of $9,666.

Q3Does KALA pay dividends?

KALA BIO, Inc. (KALA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For KALA, the total return equals the price-only return.

Q4Did KALA beat the S&P 500?

No, KALA BIO, Inc. (KALA) underperformed the S&P 500 by 127.99 percentage points over the past year. KALA delivered a total return of -96.66%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed KALA by 127.99pp during this period.

Q5What is KALA's worst drawdown?

KALA BIO, Inc. (KALA) experienced a maximum drawdown of -99.46% over the past year, declining from its peak on 2025-09-19 to its trough on 2026-04-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is KALA's long-term total return over 10, 20, or 30 years?

Here are KALA BIO, Inc. (KALA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-59.3% CAGR) — $10,000 would have grown to $1. Over 20 years: -100.0% total return (-36.2% CAGR) — $10,000 → $1. Over 30 years: -100.0% total return (-25.9% CAGR) — $10,000 → $1. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was KALA's best and worst year?

KALA BIO, Inc.'s best calendar year was 2020 with a total return of 76.6%. Its worst year was 2025 with a total return of -92.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 169.4 percentage points.